| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/16/2011 | CA2783934A1 Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
| 06/16/2011 | CA2783859A1 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2783466A1 Amyloid binding agents |
| 06/16/2011 | CA2782838A1 Bche albumin fusions for the treatment of cocaine abuse |
| 06/16/2011 | CA2782514A1 Methods of improving cognitive functions |
| 06/16/2011 | CA2782409A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands |
| 06/16/2011 | CA2781685A1 Imidazolidinedione derivatives |
| 06/16/2011 | CA2780905A1 Azocyclic inhibitors of fatty acid amide hydrolase |
| 06/15/2011 | EP2333093A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333048A1 PDGF for use in inducing proliferation of a neural progenitor cell that differentiates into neurons and oligodendrocytes by not astrocytes |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332943A1 Novel fused aminodihydrothiazine derivative |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332920A2 Processes for preparing 3-benzazepines |
| 06/15/2011 | EP2332919A2 Processes for preparing 3-benzazepines |
| 06/15/2011 | EP2332915A1 Beta2-adrenoceptor agonists |
| 06/15/2011 | EP2332910A1 New derivatives of azabicyclo[3.2.0]hept-3-yl, method for preparing same and pharmaceutical compositions containing them |
| 06/15/2011 | EP2332580A1 A composition for the treatment of the central nervous system |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332578A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/15/2011 | EP2332560A1 Use of a neurofilament peptide for the treatment of glioma |
| 06/15/2011 | EP2332559A1 Peptides for the treatment of pain |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332545A1 Composition for treating central nervous system disorders |
| 06/15/2011 | EP2332543A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine D3 receptor |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2332539A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 06/15/2011 | EP2332534A1 Phenol and benzoquinone derivatives for use in the treatment of mitochondrial diseases and modulation of energy biomarkers |
| 06/15/2011 | EP2332533A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 06/15/2011 | EP2332530A1 The use of potassium 2-( - hydroxypentyl) benzoate in the manufacture of medicaments for preventing and/or treating senile dementia |
| 06/15/2011 | EP2332525A1 Pharmaceutical composition comprising propofol |
| 06/15/2011 | EP2332523A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 06/15/2011 | EP2332424A1 Method for producing lipid |
| 06/15/2011 | EP2331571A1 Nmda receptor modulators and uses thereof |
| 06/15/2011 | EP2331563A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 06/15/2011 | EP2331561A1 Libraries of peptide conjugates and methods for making them |
| 06/15/2011 | EP2331546A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof |
| 06/15/2011 | EP2331539A2 1,3,4,6,7,11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders |
| 06/15/2011 | EP2331527A1 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 06/15/2011 | EP2331522A2 Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof |
| 06/15/2011 | EP2331505A2 Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/15/2011 | EP2331504A2 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder |
| 06/15/2011 | EP2331494A1 A process for the preparation of rotigotine |
| 06/15/2011 | EP2331210A2 Pharmaceutical combination of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an antiepileptic |
| 06/15/2011 | EP2331135A1 Methods of treating and preventing glucose toxicity |
| 06/15/2011 | EP2331102A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and an nsaid |
| 06/15/2011 | EP2331100A2 Methods and kits for treating cluster headache disorders |
| 06/15/2011 | EP2331098A1 Methods for the administration of iloperidone |
| 06/15/2011 | EP2331088A1 Compositions and methods for treating psychiatric disorders |
| 06/15/2011 | EP2331087A1 Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol |
| 06/15/2011 | EP2185561B1 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 06/15/2011 | EP2144906B1 Heterocycles as orexin antagonists |
| 06/15/2011 | EP2074086B1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 06/15/2011 | EP1937650B1 Heterocyclic compounds |
| 06/15/2011 | EP1583562B1 Angiopep-1, related compounds, and uses thereof |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP1389618B1 Pyrazolo 1,5-a pyridines and medicines containing the same |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | CN201861291U Technological cotton health-care pillow |
| 06/15/2011 | CN1968942B Novel tetracyclic tetrahydrofuran derivatives |
| 06/15/2011 | CN1946714B Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 06/15/2011 | CN1930145B Cycloalkanopyridine derivative |
| 06/15/2011 | CN1918129B Therapeutic agent |
| 06/15/2011 | CN1745817B Medicine for treating cerebral arteriosclerosis |
| 06/15/2011 | CN102099475A Treatment of pain with gap junction modulation compounds |
| 06/15/2011 | CN102099362A Selenophene and selenazole carboxylic acid derivatives |
| 06/15/2011 | CN102099360A Hydroxy substituted thieno pyrimidinones as melanin concentrating hormone receptor-1 antagonists |
| 06/15/2011 | CN102099358A Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 06/15/2011 | CN102099356A Heterocyclic derivatives as modulators of ion channels |
| 06/15/2011 | CN102099354A Azole compound |
| 06/15/2011 | CN102099344A Imidazole carboxamides |
| 06/15/2011 | CN102099339A Benzazepine derivatives and their use as hstamine h3 antagonists |
| 06/15/2011 | CN102099338A Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 06/15/2011 | CN102099337A Piperazine derivatives used as cav2.2 calcium channel modulators |
| 06/15/2011 | CN102099050A Orally administrable dosage forms comprising angiogenin and uses thereof |
| 06/15/2011 | CN102099038A Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 06/15/2011 | CN102099033A Pharmaceutical composition for treatment of fibromyalgia |
| 06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 06/15/2011 | CN102093440A Coproduction process of pig brain protein hydrolysate and monosialoganglioside |
| 06/15/2011 | CN102093387A Crystal compound of 4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridine-3-alcohol-hydrate |
| 06/15/2011 | CN102093373A Compounds formed by structural modifiecation of sinomenine and preparation method thereof |
| 06/15/2011 | CN102093234A Tromethamine salt compound of dibasic ester acid, preparation method and medicinal application thereof |
| 06/15/2011 | CN102091330A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 06/15/2011 | CN102091301A Traditional Chinese medicine composition for soothing nerves and relieving depression and application thereof |
| 06/15/2011 | CN102091297A Quality control method for liver health care medicine |
| 06/15/2011 | CN102091285A Medicinal preparation for clearing heat and restoring consciousness, preparation method thereof and application thereof |
| 06/15/2011 | CN102091283A Method for detecting Xingnaojing injection |
| 06/15/2011 | CN102091281A Smoking-quitting and toxin-reducing medicinal powder and preparation method thereof |
| 06/15/2011 | CN102091270A Medicament for treating neurodermatitis |
| 06/15/2011 | CN102091264A Traditional Chinese medicine for treating diabetic foot |
| 06/15/2011 | CN102091240A Szechuan lovage rhizome formula micro emulsion nasal delivery preparation and preparation method and application thereof |
| 06/15/2011 | CN102091239A Uncaria abalone sour soup for treating trigeminal neuralgia |
| 06/15/2011 | CN102091231A Traditional Chinese medicine composition for treating neurasthenia |
| 06/15/2011 | CN102091228A Medicine for treating insomnia and preparation method thereof |